AxoGen Inc (AXGN)

6.61
NASDAQ : Health Care
Prev Close 6.64
Day Low/High 6.51 / 6.71
52 Wk Low/High 3.26 / 7.97
Avg Volume 205.10K
Exchange NASDAQ
Shares Outstanding 30.08M
Market Cap 199.76M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

AxoGen Becomes Oversold (AXGN)

AxoGen Becomes Oversold (AXGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

3 Stocks Advancing The Health Services Industry

3 Stocks Advancing The Health Services Industry

TheStreet highlights 3 stocks that pushed the Health Services industry

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

Frost & Sullivan Applaud AxoGen's Proprietary Process For Producing Decellularized Nerve Allografts

Frost & Sullivan Applaud AxoGen's Proprietary Process For Producing Decellularized Nerve Allografts

AxoGen is the only regenerative medicine company that is completely focused on peripheral nerve repair

AxoGen, Inc. Reports Record 2012 Revenues

AxoGen, Inc. Reports Record 2012 Revenues

AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported revenues...

AxoGen, Inc. Announces Release Date Of 2012 Fourth Quarter & Year End Results And Conference Call

AxoGen, Inc. Announces Release Date Of 2012 Fourth Quarter & Year End Results And Conference Call

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that...

AxoGen To Present At Lazard Capital Markets Medical Technology Conference

AxoGen To Present At Lazard Capital Markets Medical Technology Conference

AxoGen, Inc. (OTCBB: AXGN) a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will be presenting at the Lazard Capital Markets 5 th Annual Medical...

AxoGen To Present At Noble Financial Equity Conference

AxoGen To Present At Noble Financial Equity Conference

AxoGen, Inc. (OTCBB: AXGN) a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will be presenting at Noble Financial Capital Markets' Ninth Annual ...

AxoGen, Inc. Announces Third Quarter 2012 Financial Results

AxoGen, Inc. Announces Third Quarter 2012 Financial Results

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced revenues for the third quarter ended...

AxoGen, Inc. Announces Release Dates For 2012 Third Quarter Results And Conference Call

AxoGen, Inc. Announces Release Dates For 2012 Third Quarter Results And Conference Call

AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced that it will release its financial...

AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc.

AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc.

AxoGen, Inc. (AxoGen) (OTCBB: AXGN), and PDL BioPharma, Inc.

AxoGen To Present At The Craig-Hallum Alpha Select Conference

AxoGen To Present At The Craig-Hallum Alpha Select Conference

AxoGen, Inc. (OTCBB: AXGN) today announced that it will be presenting at the Craig-Hallum 3 rd Annual Alpha Select Conference to be held at Sentry Centers in New York City.

AxoGen To Present At Noble Financial Life Sciences Conference

AxoGen To Present At Noble Financial Life Sciences Conference

AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will be presenting Monday, September 24, 2012 at the BioX –...

AxoGen, Inc. Reports Record Second Quarter 2012 Revenues

AxoGen, Inc. Reports Record Second Quarter 2012 Revenues

AxoGen, Inc. (OTCBB: AXGN): Second Quarter 2012 Highlights Record revenues of $2.

AxoGen, Inc. Announces Release Date Of 2012 Second Quarter Results And Conference Call

AxoGen, Inc. Announces Release Date Of 2012 Second Quarter Results And Conference Call

AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it...

AxoGen, Inc. Announces 2012 Annual Shareholders’ Meeting

AxoGen, Inc. Announces 2012 Annual Shareholders’ Meeting

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, announced today...

AxoGen, Inc. Makes First Commercial Shipment Of Avance® Nerve Graft To Distributor In Italy

AxoGen, Inc. Makes First Commercial Shipment Of Avance® Nerve Graft To Distributor In Italy

AxoGen, Inc. (OTCBB:AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced...

AxoGen To Present At The JMP Securities Healthcare Conference

AxoGen To Present At The JMP Securities Healthcare Conference

AxoGen, Inc. (OTCBB: AXGN) today announced that it will be presenting at the JMP Securities Healthcare Conference at The Peninsula in New York City, NY.

John AI Grossman MD (Photo: Business Wire)

John AI Grossman MD (Photo: Business Wire)

Miami Children’s Hospital, recognized by U.S.

AxoGen, Inc. Announces Record First Quarter 2012 Revenues

AxoGen, Inc. Announces Record First Quarter 2012 Revenues

AxoGen, Inc. (AXGN.